Hologic HPV Test Approved for Netherlands Cervical Screening Program | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic today announced the Netherlands Society for Pathology has approved the use of the Hologic Cervista HPV HR test in the Dutch national cervical screening program.

The National Institute for Public Health and the Environment in the Netherlands suggests routine pap testing and HPV HR triage for the ASCUS/LSIL (or atypical squamous cells of undetermined significance/ low-grade squamous intraepithelial lesion) testing for women over the age of 30 in order to identify those most likely to develop cervical cancer, Hologic said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.